Lipoprotein lipase activation by red Ginseng saponins in hyperlipidemia model animals

Phytomedicine

Volumn 6, Issue 4, 1999, Pages 257-265

  Inoue, M ^a   Wu, C Z ^a   Dou, D Q ^b   Chen, Y J ^b   Ogihara, Y ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Cyclophosphamide; Hypertriglyceridemia; Lipoprotein lipase; Red ginseng saponin

Indexed keywords

ANIMALIA; ORYCTOLAGUS CUNICULUS; PANAX GINSENG;

ANTILIPEMIC AGENT; CHYLOMICRON; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SAPONIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL; ARTICLE; BLOOD; DISEASE MODEL; DRUG EFFECT; ENZYME ACTIVATION; GINSENG; HYPERLIPIDEMIA; MALE; MEDICINAL PLANT; METABOLISM; ORAL DRUG ADMINISTRATION; PLANT ROOT; RABBIT; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTILIPEMIC AGENTS; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; CHYLOMICRONS; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; HYPERLIPIDEMIAS; LIPOPROTEIN LIPASE; MALE; PANAX; PLANT ROOTS; PLANTS, MEDICINAL; RABBITS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SAPONINS; TRIGLYCERIDES;

EID: 0033203510     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0944-7113(99)80018-X     Document Type: Article

References (43)

1. Austin, Z. A.: Plasma triglyceride and coronary heart disease. Arterio. Thromb. 11: 2-14, 1991.
2. Babirak, S. P., Iverius, P. H., Fujimoto, W. Y. and Brunzell, J. D.: Detection and characterization of the heterozygote state for lipoprotein lipase deficiency. Arteriosclerosis 9: 326-334, 1989.
3. Bar-On, H., and Stein, Y.: Effect of glucose and fructose administration on lipid metabolism in the rat. J. Nutr. 94: 95-105, 1968.
4. Bey, L., Etienne, J., Tse, C., Brault, D., Noe, L., Paisonnier, A., Arnault, F., Hamilton, M. T., and Galibert, F.: Cloning, sequencing and structural analysis of 976 base pairs of the promoter sequence for the rat lipoprotein lipase gene. Comparison with the mouse and human sequences. Gene 209: 31-38, 1998.
5. Braun, J. E. A., and Severson, D. L.: Regulation of the synthesis, processing and translocation of lipoprotein lipase. Biochem. J. 287: 337-347, 1992.
6. Brunzell, J. D.: Familial lipoprotein lipase deficiency and other causes of chylomicronemia syndrome. In The Metabolic and Molecular Basis of Inherited Disease. 7th ed. Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D., editors. McGraw-Hill, New York, 1913-1932, 1995.
7. Carroll, R., Ben-Zeev, O., Doolittle, M. H., and Severson, D. L.: Activation of lipoprotein lipase in cardiac myocytes by glycosylation requires trimming of glucose residues in the endoplasmic reticulum. Biochem. J. 285: 693-696, 1992.
8. Castelli, W. P.: The triglyceride issue: a view from Framingham. Am. Heart J. 112: 432-437, 1986.
9. Ewart, H. P., Carroll, R., and Severson, D. L.: Lipoprotein lipase activity in rat cardiomyocytes is stimulated by insulin and dexamethasone. Biochem. J. 327: 439-442, 1997.
10. Galan, X., Llobera, M., and Ramirez, I.: Lipoprotein lipase and hepatic lipase in Wistar and Sprague-Dawley rat tissues: differences in the effects of gender and fasting. Lipids 29: 333-336, 1994.
11. Goldberg, I. J.: Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J. Lipid Res. 37: 693-707, 1996.
12. Gommori, K., Miyamoto, F., Shibata, Y., Higashi, T., Sanada, S., and Shoji, J.: Effect of ginseng saponins on cholesterol metabolism, Part 2 (Effect of ginsenosides on cholesterol synthesis by liver slice). Chem. Pharm. Bull. 24: 2985-2987, 1976.
13. Hatch, F., and Less, R. S.: Preparative Ultracentrifugation. Advances in Lipid Research 6: 33 Academic press, New York, 1968.
14. Ikehara, M., Shibata, Y., Higashi, T., Sanada, S., and Shoji, J.: Effect of ginseng saponins on cholesterol metabolism, Part 3 (Effects of ginsenoside-Rb1 on cholesterol synthesis in rats fed on high-fat diets), Chem. Pharm. Bull. 26: 2844-2849, 1978.
15. Kwon, B.-M., Ro, S.-H., Kim, M.-K., Nam, J.-Y., Jung, H.-J., Lee, I.-R., Kim, Y.-K., and Bok, S.-H.: Polyacetylene analogs, isolated from hairy roots of Panax ginseng, inhibit acyl-CoA:cholesterol acyltransferase. Planta Med. 63: 552-553, 1997.
16. Kwon, B.-M., Nam, J.-Y., Lee, S.-H., Jeong, T.-S., Kim, Y.-K., and Bok, S.-H.: Isolation of cholesteryl ester transfer protein inhibitors from Panax ginseng roots, Chem. Pharm. Bull. 44: 444-445, 1996.
17. Lespine, A., Hugues, C., and Perret, B.: Impaired secretion of heart lipoprotein lipase in cyclophosphamide-treated rabbit. Biochem. Biophys. Acta 1345: 77-85, 1997.
18. Liu, C. X., and Xiao, P. G.: Recent advances on ginseng research in China. J. Ethnopharmacol. 36: 27-38, 1992.
19. Liu, M.-S., Jirik, F. R., Leboeuf, R. C., Henderson, H., Castellani, L. W., Lusis, A. J., Ma, Y., Forsythe, I. J., Zhang, H., Kirk, E., Brunzell, J. D., and Hayden, M. R.: Alteration of lipid profiles in plasma of transgenic mice expressing human lipoprotein lipase. J. Biol. Chem. 269: 11417-11424, 1994.
20. Loudet, A. M., Dousset, N., Carton, M., Douste-Blazy, L.: Effects of an antimitotic agent (cyclophosphamide) on plasa lipoproteins, Biochemical. Pharmacol. 33: 2961-2965, 1984.
21. Mano, J. C., Hirano, T., James, L., Szeto, L., and Steiner, G.: Partial characterization of the fructose-induced defect in very-low-density lipoprotein triglyceride metabolism. Metabolism 401: 888-893, 1991.
22. Miller, W. C., Gorski, J., Oscai, L. B., and Palmer, W. K.: Epinephrine activation of heparin-nonreleasable lipoprotein lipase in 3 skeletal muscle fiber types of the rat. Biochem. Biophys. Res. Commun. 164: 615-619, 1989.
23. Nilsson-Ehle, P., and Ekman, R.: Rapid, simple and specific assays for lipoprotein lipase and hepatic lipase. Artery 3: 194-209, 1977.
24. Ong, J. M., Kirchgessner, T. G., Schotz, M. C., and Kern, P. A.: Insulin increases the synthetic rate and messenger RNA level of lipoprotein lipase in isolasted rat adipocytes. J. Biol. Chem. 263: 12933-12938, 1988.
25. Pederson, M. F., and Schotz, M. C.: Rapid changes in rat heart lipoprotein lipase activity after feeding carbohydrate. J. Nutr. 110: 481-487, 1980.
26. Qureshi, A. A., Abuirmeileh, N., Din, Z. Z., Ahmad, Y., Burger, W. C., and Elson, C. E.: Suppression of cholesterogenesis and reduction of LDL cholesterol by dietary ginseng and its fractions in chicken liver. Atherosclerosis 48: 81-94, 1983.
27. Raynolds, M. V., Awald, P. D., Gordon, D. F., Gutierrez-Hartmann, A., Rule, D. C., Wood, W. M., and Eckel, R. H.: Lipoprotein lipase gene expression in rat adipocytes is regulated by isoproerenol and insulin through different mechanisms. Mol. Endocrinol. 4: 1416-1422, 1990.
28. Sakakibara, K., Shibata, Y., Higashi, T., Sanada, S., and Shoji, J.: Effect of ginseng saponins on cholesterol metabolism, Part 1 (The level and the synthesis of serum and liver cholesterol in rats treated with ginsenosides), Chem. Pharm. Bull. 23: 1009-1016, 1975.
29. Sambandam, N., Lim, F., Cam, M. C., and Rodrigues, B.: Cardiac heparin-releasable lipoprotein lipase activity in fructose-hypertensive rats: effect of coronary vasodilation. J. Cardiovasc. Pharmacol. 30: 110-117, 1997.
30. Santamarina-Fojo, S.: Genetic dyslipoproteinemia: role of lipoprotein lipase or lipoprotein C-II. Curr. Opin. Lipidol. 3: 186-195, 1992.
31. Semenkovich, C. F., Wims, M., Noe, L., Etienne, J., and Chan, L.: Insulin regulation of lipoprotein lipase activity in 3T3-L1 adipocytes is mediated at posttranscriptional and posttranslational levels. J. Biol. Chem. 264: 9030-9038, 1989.
32. Semb, H., and Olivecrona, T.: Nutritional regulation of lipoprotein lipase in guinea pig tissues. Biochim. Biophys. Acta 876: 249-255, 1986.
33. Shimada, M., Shimano, H., Gotoda, T., Yamamoto, K., Kawamura, M., Inaba, T., Yazaki, Y., and Yamada, N.: Overexpression of human lipoprotein lipase in transgenic mice. Resistance to diet-induced hypertriglyceridemia and hypercholesterolemia. J. Biol. Chem. 268: 17924-17929, 1993.
34. Tsutsumi, K., Inoue, Y., Shima, A., Iwasaki, K., Kawamura, M. and Murase, T.: The novel compound NO-1886 increases lipoprotein activity resulting elevation of high density lipoprotein cholesterol, and administration inhibits atherogenesis in the coronary arteries of rats with experimental athersclerosis. J. Clin. Invest. 92: 411-417, 1993.
35. Yamamoto, M., Uemura, T., Nakama, S., Uemiya, M., and Kumagai, A.: Serum HDL-cholesterol-increasing and fatty liver-improving actions of Panax ginseng in high cholesterol diet-fed rats with clinical effect on hyperlipidemia in man, Am. J. Chin. Med. 11: 96-101, 1983.
36. 2 in streptozotocin-diabetic rats. Chem. Pharm. Bull. 33: 3893-3898, 1985.
37. 2 treated rats. Chem. Pharm. Bull. 32: 4490-4496, 1984.
38. West, K. M., Ahuja, M. M. S., Bennett, P. H., Czyzyk, A., De Acosta, O. M., Fuller, J. H., Grab, B., Grabauskas, V., Jarrett, R. J., and Kosaka, K.: The role of circulating glucose and triglyceride concentrations and their interactios with other risk factors as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care 6: 361-369, 1983.
39. Wu, C. Z., Inoue, M., and Ogihara, Y.: Antihyperlipidemic action of a traditional Chinese medicine (Kampo medicine), Ogi-Keishi-Gomotsu-To-Ka-Kojin, Phytomed. 4: 295-300, 1997.
40. Wu, C. Z., Inoue, M., and Ogihara, Y.: Antihypercholesterolemic action of a traditional Chinese medicine (Kampo medicine), Ogi-Keishi-Gomotsu-To-Ka-Kojin. Biol. Pharm. Bull. 21: 1311-1316, 1998.
41. Zavaroni, I., Chen, Y. D., and Reaven, G. M.: Studies of the mechanism of fructose-induced hypertriglyceridemia in the rat. Metabolism 31: 1077-1083, 1982.
42. Zsigmond, E., Kobayashi, K., Tzung, K-W., Li, L., Fuke, Y., and Chan, L.: Adenovirus-mediated gene transfer of human lipoprotein lipase ameliorates the hyperlipidemia associated with apolipoprotein E and LDL receptor deficiencies in mice. Hum. Gene Thera. 8: 1921-1933, 1997.
43. Zsigmond, E., Sheffler, E., Forte, T. M., Potenz, R., Wu, W., and Chan, L.: Transgenic mice overexpressing human lipoprotein lipase driven by the mouse metallothionein promoter. A phenotype associated with in creased perinatal mortality and reduced plasma very low density lipoprotein of normal size, J. Biol. Chem. 269: 18757-18766, 1994.